Published in Nat Rev Rheumatol on August 03, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med (2017) 4.55
Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med (2005) 3.49
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum (2013) 2.28
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med (2015) 1.80
Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther (2011) 1.28
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients. Rheumatology (Oxford) (2012) 0.97